Observing a Standardized Fast-Track Stroke Care System in Xi'an Hospitals
Studies outcomes of a standardized fast-track care system for adults with acute ischemic stroke.
Plain-language title generated from the registry record
Registry title: Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an
Key facts
- Where
- Xi'an, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT05424978, who can take part
Where in China
- Xi 'an No.3 HospitalXi'an, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xi'an No.3 Hospital
- Trial code
- NCT05424978
- Record updated
- 26 January 2024
- Original description
Objective: To observe the practical application of the standardized green channel treatment system for stroke in Xi 'an in the real world. Methods: Clinical data and information of patients with acute ischemic stroke who received standardized green channel treatment for stroke were collected, and a multicenter observational clinical study was carried out in the real world to evaluate the prognosis, mortality, incidence of asymptomatic and symptomatic cerebral hemorrhage, incidence of pneumonia, and recurrence rate of stroke after 90 days.Read full original descriptionShow less
Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an
Objective: To observe the practical application of the standardized green channel treatment system for stroke in Xi 'an in the real world. Methods: Clinical data and information of patients with acute ischemic stroke who received standardized green channel treatment for stroke were collected, and a multicenter observational clinical study was carried out in the real world to evaluate the prognosis, mortality, incidence of asymptomatic and symptomatic cerebral hemorrhage, incidence of pneumonia, and recurrence rate of stroke after 90 days.
Inclusion: 18 years old; Consistent with the diagnosis of acute ischemic stroke; 24 hours from onset to enrollment; Informed consent.
Exclusion: Stroke patients caused by brain tumor, brain trauma and blood diseases; Those with a history of stroke and sequelae affecting the outcome assessment, namely, mRS 2 points before the onset of this stroke; Suffering from other serious life-threatening diseases with an expected survival time of less than 3 months; Other diseases that limit neurological function evaluation or affect patient follow-up; Patients with severe hepatic and renal insufficiency (Note: Hepatic insufficiency refers to ALT or AST values greater than 2 times the upper normal limit; Renal insufficiency refers to blood creatinine value greater than 2 times the normal upper limit); Patients who refuse to receive intravenous thrombolysis or intravascular intervention (including intravascular mechanical thrombolysis and arterial thrombolysis); Combined with claudication osteoarthritis rheumatoid arthritis gout arthritis and other limb dysfunction and affect the neurological function examination; A woman planning to be pregnant or breastfeeding; Currently participating in other clinical trials; Refuse to participate in the registration of investigators.